世界の膵臓がん診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pancreatic Cancer Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4415 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、膵臓がん診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（画像、腫瘍バイオマーカー、生検）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・膵臓がん診断の市場動向 ・企業の競争状況、市場シェア ・膵臓がん診断の種類別市場規模（画像、腫瘍バイオマーカー、生検） ・膵臓がん診断の用途別市場規模（病院、診療所） ・膵臓がん診断の北米市場規模2016-2027（アメリカ、カナダ） ・膵臓がん診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・膵臓がん診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・膵臓がん診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・膵臓がん診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Siemens、GE Healthcare、Roche、Philips Healthcare、Danaher、Canon Medical Systems、Abbott、Hitachi Medical、Qiagen、Myriad Genetics） ・結論

Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and the term “pancreatic cancer” is sometimes used to refer only to that type. These adenocarcinomas start within the part of the pancreas that makes digestive enzymes. Several other types of cancer, which collectively represent the majority of the no adenocarcinomas, can also arise from these cells. About 1-2% of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma.
The classification of pancreatic cancer diagnostics includes tumor biomarker tests, imaging, biopsy and other, and most of Pancreatic Cancer Diagnostics use the method of imaging, the proportion of imaging in 2019 is about 64%.
Pancreatic cancer diagnostics is widely used in the hospitals, clinics and others. The most proportion of pancreatic cancer diagnostics is used in the Hospitals with the proportion is about 47% in 2019.
North America is the largest sales place, with a consumption value market share nearly 43% in 2019. Following North America, Europe is the second largest sales place with the consumption market share of about 29%.

Market Analysis and Insights: Global Pancreatic Cancer Diagnostic Market
The global Pancreatic Cancer Diagnostic market size is projected to reach US$ 8016.3 million by 2026, from US$ 5128.5 million in 2019, at a CAGR of 7.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pancreatic Cancer Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pancreatic Cancer Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pancreatic Cancer Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pancreatic Cancer Diagnostic market.

Global Pancreatic Cancer Diagnostic Scope and Market Size
Pancreatic Cancer Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Cancer Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Imaging
Tumor Biomarker
Biopsy

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Siemens
GE Healthcare
Roche
Philips Healthcare
Danaher
Canon Medical Systems
Abbott
Hitachi Medical
Qiagen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Imaging
1.2.3 Tumor Biomarker
1.2.4 Biopsy
1.3 Market by Application
1.3.1 Global Pancreatic Cancer Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pancreatic Cancer Diagnostic Market Perspective (2016-2027)
2.2 Pancreatic Cancer Diagnostic Growth Trends by Regions
2.2.1 Pancreatic Cancer Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pancreatic Cancer Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Pancreatic Cancer Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Pancreatic Cancer Diagnostic Industry Dynamic
2.3.1 Pancreatic Cancer Diagnostic Market Trends
2.3.2 Pancreatic Cancer Diagnostic Market Drivers
2.3.3 Pancreatic Cancer Diagnostic Market Challenges
2.3.4 Pancreatic Cancer Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Cancer Diagnostic Players by Revenue
3.1.1 Global Top Pancreatic Cancer Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Pancreatic Cancer Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Pancreatic Cancer Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Cancer Diagnostic Revenue
3.4 Global Pancreatic Cancer Diagnostic Market Concentration Ratio
3.4.1 Global Pancreatic Cancer Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Diagnostic Revenue in 2020
3.5 Pancreatic Cancer Diagnostic Key Players Head office and Area Served
3.6 Key Players Pancreatic Cancer Diagnostic Product Solution and Service
3.7 Date of Enter into Pancreatic Cancer Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pancreatic Cancer Diagnostic Breakdown Data by Type
4.1 Global Pancreatic Cancer Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Pancreatic Cancer Diagnostic Forecasted Market Size by Type (2022-2027)

5 Pancreatic Cancer Diagnostic Breakdown Data by Application
5.1 Global Pancreatic Cancer Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Pancreatic Cancer Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pancreatic Cancer Diagnostic Market Size (2016-2027)
6.2 North America Pancreatic Cancer Diagnostic Market Size by Type
6.2.1 North America Pancreatic Cancer Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Pancreatic Cancer Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Pancreatic Cancer Diagnostic Market Size by Type (2016-2027)
6.3 North America Pancreatic Cancer Diagnostic Market Size by Application
6.3.1 North America Pancreatic Cancer Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Pancreatic Cancer Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Pancreatic Cancer Diagnostic Market Size by Application (2016-2027)
6.4 North America Pancreatic Cancer Diagnostic Market Size by Country
6.4.1 North America Pancreatic Cancer Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Pancreatic Cancer Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pancreatic Cancer Diagnostic Market Size (2016-2027)
7.2 Europe Pancreatic Cancer Diagnostic Market Size by Type
7.2.1 Europe Pancreatic Cancer Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Pancreatic Cancer Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Pancreatic Cancer Diagnostic Market Size by Type (2016-2027)
7.3 Europe Pancreatic Cancer Diagnostic Market Size by Application
7.3.1 Europe Pancreatic Cancer Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Pancreatic Cancer Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Pancreatic Cancer Diagnostic Market Size by Application (2016-2027)
7.4 Europe Pancreatic Cancer Diagnostic Market Size by Country
7.4.1 Europe Pancreatic Cancer Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Pancreatic Cancer Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Type
8.2.1 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Application
8.3.1 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Region
8.4.1 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pancreatic Cancer Diagnostic Market Size (2016-2027)
9.2 Latin America Pancreatic Cancer Diagnostic Market Size by Type
9.2.1 Latin America Pancreatic Cancer Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Pancreatic Cancer Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Pancreatic Cancer Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Pancreatic Cancer Diagnostic Market Size by Application
9.3.1 Latin America Pancreatic Cancer Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Pancreatic Cancer Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Pancreatic Cancer Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Pancreatic Cancer Diagnostic Market Size by Country
9.4.1 Latin America Pancreatic Cancer Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Pancreatic Cancer Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type
10.2.1 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application
10.3.1 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Country
10.4.1 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens Pancreatic Cancer Diagnostic Introduction
11.1.4 Siemens Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.1.5 Siemens Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Pancreatic Cancer Diagnostic Introduction
11.2.4 GE Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Pancreatic Cancer Diagnostic Introduction
11.3.4 Roche Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Philips Healthcare
11.4.1 Philips Healthcare Company Details
11.4.2 Philips Healthcare Business Overview
11.4.3 Philips Healthcare Pancreatic Cancer Diagnostic Introduction
11.4.4 Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.4.5 Philips Healthcare Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Pancreatic Cancer Diagnostic Introduction
11.5.4 Danaher Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.5.5 Danaher Recent Development
11.6 Canon Medical Systems
11.6.1 Canon Medical Systems Company Details
11.6.2 Canon Medical Systems Business Overview
11.6.3 Canon Medical Systems Pancreatic Cancer Diagnostic Introduction
11.6.4 Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.6.5 Canon Medical Systems Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Pancreatic Cancer Diagnostic Introduction
11.7.4 Abbott Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 Hitachi Medical
11.8.1 Hitachi Medical Company Details
11.8.2 Hitachi Medical Business Overview
11.8.3 Hitachi Medical Pancreatic Cancer Diagnostic Introduction
11.8.4 Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.8.5 Hitachi Medical Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Pancreatic Cancer Diagnostic Introduction
11.9.4 Qiagen Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.9.5 Qiagen Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Introduction
11.10.4 Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Business (2016-2021)
11.10.5 Myriad Genetics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Imaging
Table 3. Key Players of Tumor Biomarker
Table 4. Key Players of Biopsy
Table 5. Global Pancreatic Cancer Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pancreatic Cancer Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pancreatic Cancer Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pancreatic Cancer Diagnostic Market Share by Regions (2016-2021)
Table 9. Global Pancreatic Cancer Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pancreatic Cancer Diagnostic Market Share by Regions (2022-2027)
Table 11. Pancreatic Cancer Diagnostic Market Trends
Table 12. Pancreatic Cancer Diagnostic Market Drivers
Table 13. Pancreatic Cancer Diagnostic Market Challenges
Table 14. Pancreatic Cancer Diagnostic Market Restraints
Table 15. Global Pancreatic Cancer Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pancreatic Cancer Diagnostic Market Share by Players (2016-2021)
Table 17. Global Top Pancreatic Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Diagnostic as of 2020)
Table 18. Ranking of Global Top Pancreatic Cancer Diagnostic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pancreatic Cancer Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pancreatic Cancer Diagnostic Product Solution and Service
Table 22. Date of Enter into Pancreatic Cancer Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2016-2021)
Table 26. Global Pancreatic Cancer Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pancreatic Cancer Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pancreatic Cancer Diagnostic Revenue Market Share by Application (2016-2021)
Table 30. Global Pancreatic Cancer Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pancreatic Cancer Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pancreatic Cancer Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pancreatic Cancer Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pancreatic Cancer Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pancreatic Cancer Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pancreatic Cancer Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pancreatic Cancer Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pancreatic Cancer Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pancreatic Cancer Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pancreatic Cancer Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pancreatic Cancer Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pancreatic Cancer Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pancreatic Cancer Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Siemens Company Details
Table 63. Siemens Business Overview
Table 64. Siemens Pancreatic Cancer Diagnostic Product
Table 65. Siemens Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 66. Siemens Recent Development
Table 67. GE Healthcare Company Details
Table 68. GE Healthcare Business Overview
Table 69. GE Healthcare Pancreatic Cancer Diagnostic Product
Table 70. GE Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 71. GE Healthcare Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Pancreatic Cancer Diagnostic Product
Table 75. Roche Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Philips Healthcare Company Details
Table 78. Philips Healthcare Business Overview
Table 79. Philips Healthcare Pancreatic Cancer Diagnostic Product
Table 80. Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 81. Philips Healthcare Recent Development
Table 82. Danaher Company Details
Table 83. Danaher Business Overview
Table 84. Danaher Pancreatic Cancer Diagnostic Product
Table 85. Danaher Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. Canon Medical Systems Company Details
Table 88. Canon Medical Systems Business Overview
Table 89. Canon Medical Systems Pancreatic Cancer Diagnostic Product
Table 90. Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 91. Canon Medical Systems Recent Development
Table 92. Abbott Company Details
Table 93. Abbott Business Overview
Table 94. Abbott Pancreatic Cancer Diagnostic Product
Table 95. Abbott Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 96. Abbott Recent Development
Table 97. Hitachi Medical Company Details
Table 98. Hitachi Medical Business Overview
Table 99. Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 100. Hitachi Medical Recent Development
Table 101. Qiagen Company Details
Table 102. Qiagen Business Overview
Table 103. Qiagen Pancreatic Cancer Diagnostic Product
Table 104. Qiagen Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 105. Qiagen Recent Development
Table 106. Myriad Genetics Company Details
Table 107. Myriad Genetics Business Overview
Table 108. Myriad Genetics Pancreatic Cancer Diagnostic Product
Table 109. Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Business (2016-2021) & (US$ Million)
Table 110. Myriad Genetics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Cancer Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Imaging Features
Figure 3. Tumor Biomarker Features
Figure 4. Biopsy Features
Figure 5. Global Pancreatic Cancer Diagnostic Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Pancreatic Cancer Diagnostic Report Years Considered
Figure 9. Global Pancreatic Cancer Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pancreatic Cancer Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pancreatic Cancer Diagnostic Market Share by Regions: 2020 VS 2027
Figure 12. Global Pancreatic Cancer Diagnostic Market Share by Regions (2022-2027)
Figure 13. Global Pancreatic Cancer Diagnostic Market Share by Players in 2020
Figure 14. Global Top Pancreatic Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Diagnostic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pancreatic Cancer Diagnostic Revenue in 2020
Figure 16. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2016-2021)
Figure 17. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2022-2027)
Figure 18. North America Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pancreatic Cancer Diagnostic Market Share by Type (2016-2027)
Figure 20. North America Pancreatic Cancer Diagnostic Market Share by Application (2016-2027)
Figure 21. North America Pancreatic Cancer Diagnostic Market Share by Country (2016-2027)
Figure 22. United States Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pancreatic Cancer Diagnostic Market Share by Type (2016-2027)
Figure 26. Europe Pancreatic Cancer Diagnostic Market Share by Application (2016-2027)
Figure 27. Europe Pancreatic Cancer Diagnostic Market Share by Country (2016-2027)
Figure 28. Germany Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pancreatic Cancer Diagnostic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pancreatic Cancer Diagnostic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pancreatic Cancer Diagnostic Market Share by Region (2016-2027)
Figure 38. China Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pancreatic Cancer Diagnostic Market Share by Type (2016-2027)
Figure 46. Latin America Pancreatic Cancer Diagnostic Market Share by Application (2016-2027)
Figure 47. Latin America Pancreatic Cancer Diagnostic Market Share by Country (2016-2027)
Figure 48. Mexico Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pancreatic Cancer Diagnostic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pancreatic Cancer Diagnostic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pancreatic Cancer Diagnostic Market Share by Country (2016-2027)
Figure 54. Turkey Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pancreatic Cancer Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Siemens Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 58. GE Healthcare Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 60. Philips Healthcare Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 61. Danaher Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 62. Canon Medical Systems Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 64. Hitachi Medical Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 65. Qiagen Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 66. Myriad Genetics Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---